Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janick Selves

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
NPJ Precision Oncology|July 18, 2024
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohortNicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon, et al.
BMC Cancer|October 12, 2023
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma-randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocolAnouchka Modesto, David Tougeron, Pierre Tremolières, et al.
Genes, Chromosomes & Cancer|July 10, 2021
CARMN-NOTCH2 fusion transcript drives high NOTCH2 expression in glomus tumors of the upper digestive tractNicolas Girard, Cristi Marin, Zofia Hélias-Rodzewicz, et al.
Plos Medicine|May 24, 2013
Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic valueLaetitia Marisa, Aurélien de Reyniès, Alex Duval, et al.
Cancers|September 10, 2021
A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III TumorsPascale Palassin, Marion Lapierre, Samuel Pyrdziak, et al.
Journal of the National Cancer Institute|September 20, 2017
The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon TumorsLaetitia Marisa, Magali Svrcek, Ada Collura, et al.
Nature Medicine|September 28, 2011
Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosisCoralie Dorard, Aurélie de Thonel, Ada Collura, et al.
Gastroenterology|December 13, 2016
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant TransformationJean-Charles Nault, Gabrielle Couchy, Charles Balabaud, et al.
The Lancet Regional Health. Europe|November 24, 2025
Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysisCélia Dupain, Nicolas Jacquin, Aurélien Latouche, et al.
Journal of Medical Genetics|February 3, 2016
HSP110 T17 simplifies and improves the microsatellite instability testing in patients with colorectal cancerOlivier Buhard, Anaïs Lagrange, Agathe Guilloux, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
NPJ Precision Oncology|July 18, 2024
Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohortNicolas Jacquin, Ronan Flippot, Julien Masliah-Planchon, et al.
BMC Cancer|October 12, 2023
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma-randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocolAnouchka Modesto, David Tougeron, Pierre Tremolières, et al.
Genes, Chromosomes & Cancer|July 10, 2021
CARMN-NOTCH2 fusion transcript drives high NOTCH2 expression in glomus tumors of the upper digestive tractNicolas Girard, Cristi Marin, Zofia Hélias-Rodzewicz, et al.
Plos Medicine|May 24, 2013
Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic valueLaetitia Marisa, Aurélien de Reyniès, Alex Duval, et al.
Cancers|September 10, 2021
A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III TumorsPascale Palassin, Marion Lapierre, Samuel Pyrdziak, et al.
Journal of the National Cancer Institute|September 20, 2017
The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon TumorsLaetitia Marisa, Magali Svrcek, Ada Collura, et al.
Nature Medicine|September 28, 2011
Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosisCoralie Dorard, Aurélie de Thonel, Ada Collura, et al.
Gastroenterology|December 13, 2016
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant TransformationJean-Charles Nault, Gabrielle Couchy, Charles Balabaud, et al.
The Lancet Regional Health. Europe|November 24, 2025
Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysisCélia Dupain, Nicolas Jacquin, Aurélien Latouche, et al.
Journal of Medical Genetics|February 3, 2016
HSP110 T17 simplifies and improves the microsatellite instability testing in patients with colorectal cancerOlivier Buhard, Anaïs Lagrange, Agathe Guilloux, et al.
Pageof 12